Company news
Engene Holdings Inc. (DUS:S0N) news
Engene Holdings Inc. news releases on 6ix. Latest, Apr 7, 2026: enGene Announces Name Change to enGene Therapeutics Inc.
Press releases & updates
enGene Announces Name Change to enGene Therapeutics Inc.
April 7, 2026
enGene Reports First Quarter 2026 Financial Results and Provides Business Update
March 9, 2026
enGene to Participate in Upcoming Investor Conferences
February 20, 2026
enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 4, 2026
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
January 20, 2026
enGene Reports Full Year 2025 Financial Results and Provides Business Update
December 22, 2025
Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors
December 16, 2025
enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness
December 2, 2025
enGene to Present at the Piper Sandler 37th Annual Healthcare Conference
November 25, 2025
enGene Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants
November 13, 2025
enGene Announces Proposed Public Offering of Common Shares
November 12, 2025
Detalimogene Demonstrates Improved Complete Response Rate of 62% at 6 Months
November 11, 2025
enGene to Host Conference Call to Provide Update on Pivotal Cohort of LEGEND Trial
November 10, 2025
enGene Named a BioSpace 2026 Best Places to Work Winner
November 4, 2025